|
π
|
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
24 auth.
M. Gnant,
M. Filipits,
R. Greil,
H. Stoeger,
M. Rudas,
Z. Bago-Horvath,
B. Mlineritsch,
W. Kwasny,
M. Knauer,
C. Singer,
...
R. Jakesz,
P. Dubsky,
F. Fitzal,
R. Bartsch,
G. Steger,
M. BaliΔ,
S. Ressler,
J. Cowens,
J. Storhoff,
S. Ferree,
C. Schaper,
S. Liu,
C. Fesl,
T. Nielsen
|
8 |
2014 |
8
π
|
|
π
|
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b-2 trial.
20 auth.
S. Loi,
A. Giobbie-Hurder,
A. Gombos,
T. Bachelot,
R. Hui,
G. Curigliano,
M. Campone,
L. Biganzoli,
H. Bonnefoi,
G. Jerusalem,
...
R. Bartsch,
M. Rabaglio-Poretti,
R. Kammler,
R. Maibach,
M. Smyth,
A. Di Leo,
M. Colleoni,
G. Viale,
M. Regan,
F. AndrΓ©
|
8 |
2019 |
8
π
|
|
π
|
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
25 auth.
M. Gnant,
B. Mlineritsch,
H. Stoeger,
G. Luschin-Ebengreuth,
M. Knauer,
M. Moik,
R. Jakesz,
M. Seifert,
S. Taucher,
V. Bjelic-Radisic,
M. BaliΔ,
H. Eidtmann,
W. Eiermann,
G. Steger,
W. Kwasny,
...
P. Dubsky,
U. Selim,
F. Fitzal,
G. Hochreiner,
V. Wette,
P. Sevelda,
F. Ploner,
R. Bartsch,
C. Fesl,
R. Greil
|
8 |
2015 |
8
π
|
|
π¦
|
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
23 auth.
R. Bartsch,
A. Berghoff,
J. Furtner,
M. Marhold,
E. Bergen,
S. Roider-Schur,
A. Starzer,
H. Forstner,
B. Rottenmanner,
K. Dieckmann,
...
Z. Bago-Horvath,
H. Haslacher,
G. Widhalm,
A. Ilhan-Mutlu,
C. Minichsdorfer,
T. Fuereder,
T. Szekeres,
L. Oehler,
B. Gruenberger,
C. Singer,
A. Weltermann,
R. Puhr,
M. Preusser
|
7 |
2022 |
7
π¦
|
|
π
|
Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases
17 auth.
A. Berghoff,
Elisabeth Fuchs,
G. Ricken,
B. Mlecnik,
G. Bindea,
Thomas Spanberger,
M. Hackl,
G. Widhalm,
K. Dieckmann,
D. Prayer,
...
AmΓ©lie M. Bilocq,
H. Heinzl,
C. Zielinski,
R. Bartsch,
P. Birner,
J. Galon,
M. Preusser
|
7 |
2016 |
7
π
|
|
π
|
Invasion patterns in brain metastases of solid cancers.
10 auth.
A. Berghoff,
Orsolya Rajky,
F. Winkler,
R. Bartsch,
J. Furtner,
J. Hainfellner,
...
S. Goodman,
M. Weller,
J. Schittenhelm,
M. Preusser
|
7 |
2013 |
7
π
|
|
π
|
Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients
13 auth.
Amirhessam Tahmassebi,
G. Wengert,
T. Helbich,
Z. Bago-Horvath,
S. Alaei,
R. Bartsch,
P. Dubsky,
P. Baltzer,
P. Clauser,
P. Kapetas,
...
E. Morris,
A. Meyer-Baese,
K. Pinker
|
7 |
2019 |
7
π
|
|
π
|
Brain metastases: pathobiology and emerging targeted therapies
12 auth.
M. Preusser,
D. Capper,
A. Ilhan-Mutlu,
A. Berghoff,
P. Birner,
R. Bartsch,
...
C. Marosi,
C. Zielinski,
M. Mehta,
F. Winkler,
W. Wick,
A. Deimling
|
7 |
2012 |
7
π
|
|
π
|
Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
11 auth.
A. Berghoff,
S. Schur,
Lisa FΓΌreder,
B. Gatterbauer,
K. Dieckmann,
G. Widhalm,
...
J. Hainfellner,
C. Zielinski,
P. Birner,
R. Bartsch,
M. Preusser
|
7 |
2016 |
7
π
|
|
π¦
|
Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.
9 auth.
R. Bartsch,
C. Wenzel,
Gabriela Altorjai,
U. Pluschnig,
M. Rudas,
R. Mader,
...
Michael Gnant,
C. Zielinski,
G. Steger
|
7 |
2007 |
7
π¦
|
|
π
|
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients
9 auth.
B. Petricevic,
J. Laengle,
J. Singer,
M. Sachet,
J. Fazekas,
G. Steger,
...
R. Bartsch,
E. JensenβJarolim,
M. Bergmann
|
7 |
2013 |
7
π
|
